Clinical Researcher—February 2020 (Volume 34, Issue 2) FORM & FUNCTION Lindsay McNair, MD, MPH, MSB For many years, the randomized, parallel-group, double-blinded clinical trial was considered the optimal study […]
One of the top reasons clinical trial professionals move from job to job in today’s high-turnover market is a feeling of stagnation in their current role, according to a new […]
Decentralized clinical trials (DCTs) offer opportunities to optimize efficiencies in clinical trials, a number of U.S. Food and Drug Administration (FDA) officials, including Dr. Isaac R. Rodriguez-Chavez, have said at […]
The U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) just laid down the gauntlet in a document promising an active 2020 chock full of guidances […]